submucous fibroids
Conditions
Interventions
Control group:Hysteroscopic resection.
Experimental group:QuikClear hysteroscopic tissue resection system group
Sponsors
The Third Affiliated Hospital of Zhengzhou University
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1) Patients who voluntarily sign informed consent to participate in the clinical trial on the basis of full understanding after fully explaining the purpose and content of the clinical trial, including the subject's compliance. 2) Age 20-45 years old 3) Patients with benign uterine lesions were diagnosed after hysteroscopy. 4) Patients with diagnostic curettage or blunt dissociation are difficult to remove. 5) Type 0, type 1 or type 2 uterine submucous fibroids (diameter = 4 cm). 6) Sexual life history.
Exclusion criteria
Exclusion criteria: 1) There is no clear clinical diagnosis. 2) Suspected cancer or precancer combined with endometrial cancer. 3) The liquid based cytology of the cervix indicates abnormalities. 4) Patients with acute and chronic infectious diseases, severe liver and kidney dysfunction and coagulation mechanism disorders. 5) Subjects with a serious physical or mental illness that the investigator believes may interfere with treatment, evaluation, or poor adherence to the study protocol. 6) Patients who cannot tolerate surgery. 7) Unable to dilate the cervix due to cervical scar.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effectiveness; | — |
Secondary
| Measure | Time frame |
|---|---|
| Security;Postoperative pregnancy;Satisfaction evaluation;Clinical performance; | — |
Countries
China
Contacts
Public ContactLi Yang
The Third Affiliated Hospital of Zhengzhou University
Outcome results
None listed